The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The Pharma 4.0™ and Annex 1 Regulatory Panel Discussion will bring together regulators from around the world to provide insights on the implementation of Pharma 4.0 concepts to different manufacturing technologies. Panelists will discuss the interpretation and practical application of current standards and regulations in the context of digitalization, and outline opportunities for future harmonization that can facilitate digital transformation including technologies such as the use of Artificial Intelligence.
Join an insightful panel discussion powered and led by ISPE’s Women in Pharma on "Leadership Agility: Adapting to the Evolving Landscape of the Pharmaceutical Industry…
The digital revolution in medicine manufacturing offers opportunities for better understanding and control of the manufacturing processes and therefore better quality of medicines for patients and faster scale up/out with positive impact on medicine availability…